Sidney Cohen, MD
Gastroesophageal reflux disease is a clinical syndrome that manifests as heartburn and the sequelae of esophagitis, ulceration, stricture, or Barrett epithelium. Adenocarcinoma of the esophagus in association with metaplastic columnar or Barrett epithelium is one of the most rapidly increasing malignancies recognized in the United States. Gastroesophageal reflux disease with its associated sequelae can now be readily diagnosed and effectively managed with histamine-2 antagonists, prokinetic agents, omeprazole, or antireflux surgery.
Despite improved diagnosis and management of gastroesophageal reflux, the pathogenesis of this condition has remained controversial. The article by Sloan and colleagues (1), in this issue of Annals, uses modern
Cohen S. The Pathogenesis of Gastroesophageal Reflux Disease: A Challenge in Clinical Physiology. Ann Intern Med. 1992;117:1051–1052. doi: 10.7326/0003-4819-117-12-1051
Download citation file:
Published: Ann Intern Med. 1992;117(12):1051-1052.
Esophageal Disorders, Gastroenterology/Hepatology, Gastroesophageal Reflux Disease, Peptic Disease.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use